October 10, 2024
Snapshot Top 10: Dow Jones U.S. Pharmaceuticals Index
The Top 10 performing stocks in the Dow Jones U.S. Pharmaceuticals Index are shown for seven different investment strategies. Whether you are looking for value, growth or dividend stocks, or you want stocks that rank well overall, you can see the top 10 stock picks, together with how they rank on a scale of 1 to 100 from the perspective of different investment strategies. We have also added our newest Sentiment and 360° View ranks, which encapsulate the market voices of analysts and professional investors into a simple ranking for easily evaluating stocks. As an objective research provider, Obermatt has been refining its stock analysis algorithms for more than 10 years (no AI used here!)
Select any stock for the detailed analysis of that stock's performance across the different investment analyses. Please note that the Top 10 stocks focus only on Large to XX-Large companies.
What the six ranks mean
For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies:Value - shows how good of a value the stock is. Green is "inexpensive"; red is "expensive".
Growth - shows a company's growth potential. Green is "high growth" expected; red is "tough times ahead".
Safety - relates to the amount of debt a company has. Green is low debt level; red is high debt level.
Combined Financial - this isn't an average of the first three ranks but rather a consolidated view across several financial indicators. Green = good; red = tread carefully.
(NEW ) Sentiment - quantifies professional analyst ratings and holdings as well as market pulse. Green = positive sentiment; red = skepticism (Only available to Premium Subscribers).
(NEW ) 360° View - the ultimate rating with all financial and non-financial indicators.
Special Analysis: TOP 10 Dividend Investment Strategy
Many people ask for tips about dividend stocks. These are the Top 10 dividend stocks in the Dow Jones U.S. Pharmaceuticals Index as of October 10, 2024.
TOP 10 Dividend Investment Strategy
DIVIDEND
VALUE
COMBINED
360° VIEW
1. Pfizer (XXL, US) Pharmaceuticals
1. Pfizer (XXL, US) Pharmaceuticals
100
99
59
67
2. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
2. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
98
89
32
23
3. Johnson & Johnson (XXL, US) Pharmaceuticals
3. Johnson & Johnson (XXL, US) Pharmaceuticals
94
57
49
40
4. Phibro Animal (L, US) Pharmaceuticals
4. Phibro Animal (L, US) Pharmaceuticals
92
99
100
85
5. Merck & Co. (XXL, US) Pharmaceuticals
5. Merck & Co. (XXL, US) Pharmaceuticals
90
75
83
85
6. Zoetis (XL, US) Pharmaceuticals
6. Zoetis (XL, US) Pharmaceuticals
86
17
23
50
7. Eli Lilly (XXL, US) Pharmaceuticals
7. Eli Lilly (XXL, US) Pharmaceuticals
86
17
41
56
☀ This company has a special achievement which is documented on its stock research page.
October 10, 2024. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
D.J. US Pharmaceutical Top 10: Obermatt 360° Investment Strategy
TOP 10 Obermatt 360° Investment Strategy
360° VIEW
VALUE
COMBINED
SENTIMENT
1. Assertio Therapeutics (S, US) Pharmaceuticals
1. Assertio Therapeutics (S, US) Pharmaceuticals
92
73
100
43
2. Merck & Co. (XXL, US) Pharmaceuticals
2. Merck & Co. (XXL, US) Pharmaceuticals
85
75
83
71
3. Phibro Animal (L, US) Pharmaceuticals
3. Phibro Animal (L, US) Pharmaceuticals
85
99
100
5
4. Amphastar (M, US) Pharmaceuticals
4. Amphastar (M, US) Pharmaceuticals
74
31
61
85
5. Prestige (L, US) Pharmaceuticals
5. Prestige (L, US) Pharmaceuticals
74
53
43
100
6. Pfizer (XXL, US) Pharmaceuticals
6. Pfizer (XXL, US) Pharmaceuticals
67
99
59
63
7. Eli Lilly (XXL, US) Pharmaceuticals
7. Eli Lilly (XXL, US) Pharmaceuticals
56
17
41
77
8. Zoetis (XL, US) Pharmaceuticals
8. Zoetis (XL, US) Pharmaceuticals
50
17
23
93
9. Pacira BioSciences (M, US) Pharmaceuticals
9. Pacira BioSciences (M, US) Pharmaceuticals
45
91
78
21
10. Johnson & Johnson (XXL, US) Pharmaceuticals
10. Johnson & Johnson (XXL, US) Pharmaceuticals
40
57
49
47
October 10, 2024. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
D.J. US Pharmaceutical Top 10: Sentiment Investment Strategy
TOP 10 Sentiment Investment Strategy
SENTIMENT
VALUE
COMBINED
360° VIEW
1. Prestige (L, US) Pharmaceuticals
1. Prestige (L, US) Pharmaceuticals
100
53
43
74
2. Zoetis (XL, US) Pharmaceuticals
2. Zoetis (XL, US) Pharmaceuticals
93
17
23
50
3. Amphastar (M, US) Pharmaceuticals
3. Amphastar (M, US) Pharmaceuticals
85
31
61
74
4. Eli Lilly (XXL, US) Pharmaceuticals
4. Eli Lilly (XXL, US) Pharmaceuticals
77
17
41
56
5. Merck & Co. (XXL, US) Pharmaceuticals
5. Merck & Co. (XXL, US) Pharmaceuticals
71
75
83
85
6. Pfizer (XXL, US) Pharmaceuticals
6. Pfizer (XXL, US) Pharmaceuticals
63
99
59
67
7. Johnson & Johnson (XXL, US) Pharmaceuticals
7. Johnson & Johnson (XXL, US) Pharmaceuticals
47
57
49
40
8. Assertio Therapeutics (S, US) Pharmaceuticals
8. Assertio Therapeutics (S, US) Pharmaceuticals
43
73
100
92
9. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
9. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
31
89
32
23
October 10, 2024. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
D.J. US Pharmaceutical Top 10: Value Investment Strategy
TOP 10 Value Investment Strategy
VALUE
GROWTH
COMBINED
360° VIEW
1. Pfizer (XXL, US) Pharmaceuticals
1. Pfizer (XXL, US) Pharmaceuticals
99
39
59
67
2. Phibro Animal (L, US) Pharmaceuticals
2. Phibro Animal (L, US) Pharmaceuticals
99
63
100
85
3. Pacira BioSciences (M, US) Pharmaceuticals
3. Pacira BioSciences (M, US) Pharmaceuticals
91
3
78
45
4. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
4. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
89
7
32
23
5. Merck & Co. (XXL, US) Pharmaceuticals
5. Merck & Co. (XXL, US) Pharmaceuticals
75
69
83
85
6. Assertio Therapeutics (S, US) Pharmaceuticals
6. Assertio Therapeutics (S, US) Pharmaceuticals
73
63
100
92
7. Johnson & Johnson (XXL, US) Pharmaceuticals
7. Johnson & Johnson (XXL, US) Pharmaceuticals
57
25
49
40
8. Prestige (L, US) Pharmaceuticals
8. Prestige (L, US) Pharmaceuticals
53
43
43
74
9. Amphastar (M, US) Pharmaceuticals
9. Amphastar (M, US) Pharmaceuticals
31
69
61
74
10. Supernus Pharma (M, US) Pharmaceuticals
10. Supernus Pharma (M, US) Pharmaceuticals
29
9
30
19
October 10, 2024. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
D.J. US Pharmaceutical Top 10: Growth Investment Strategy
TOP 10 Growth Investment Strategy
GROWTH
VALUE
COMBINED
360° VIEW
1. Eli Lilly (XXL, US) Pharmaceuticals
1. Eli Lilly (XXL, US) Pharmaceuticals
97
17
41
56
2. Catalent (XL, US) Pharmaceuticals
2. Catalent (XL, US) Pharmaceuticals
83
9
12
10
3. Nektar (S, US) Pharmaceuticals
3. Nektar (S, US) Pharmaceuticals
79
9
72
34
4. Merck & Co. (XXL, US) Pharmaceuticals
4. Merck & Co. (XXL, US) Pharmaceuticals
69
75
83
85
5. Amphastar (M, US) Pharmaceuticals
5. Amphastar (M, US) Pharmaceuticals
69
31
61
74
6. Assertio Therapeutics (S, US) Pharmaceuticals
6. Assertio Therapeutics (S, US) Pharmaceuticals
63
73
100
92
7. Phibro Animal (L, US) Pharmaceuticals
7. Phibro Animal (L, US) Pharmaceuticals
63
99
100
85
8. Zoetis (XL, US) Pharmaceuticals
8. Zoetis (XL, US) Pharmaceuticals
61
17
23
50
9. Prestige (L, US) Pharmaceuticals
9. Prestige (L, US) Pharmaceuticals
43
53
43
74
10. Pfizer (XXL, US) Pharmaceuticals
10. Pfizer (XXL, US) Pharmaceuticals
39
99
59
67
October 10, 2024. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
D.J. US Pharmaceutical Top 10: Safety Investment Strategy
TOP 10 Safety Investment Strategy
SAFETY
VALUE
COMBINED
360° VIEW
1. Supernus Pharma (M, US) Pharmaceuticals
1. Supernus Pharma (M, US) Pharmaceuticals
100
29
30
19
2. Assertio Therapeutics (S, US) Pharmaceuticals
2. Assertio Therapeutics (S, US) Pharmaceuticals
96
73
100
92
3. Nektar (S, US) Pharmaceuticals
3. Nektar (S, US) Pharmaceuticals
94
9
72
34
4. Pacira BioSciences (M, US) Pharmaceuticals
4. Pacira BioSciences (M, US) Pharmaceuticals
94
91
78
45
5. Phibro Animal (L, US) Pharmaceuticals
5. Phibro Animal (L, US) Pharmaceuticals
88
99
100
85
6. Johnson & Johnson (XXL, US) Pharmaceuticals
6. Johnson & Johnson (XXL, US) Pharmaceuticals
70
57
49
40
7. Amphastar (M, US) Pharmaceuticals
7. Amphastar (M, US) Pharmaceuticals
67
31
61
74
8. Zoetis (XL, US) Pharmaceuticals
8. Zoetis (XL, US) Pharmaceuticals
48
17
23
50
9. Merck & Co. (XXL, US) Pharmaceuticals
9. Merck & Co. (XXL, US) Pharmaceuticals
48
75
83
85
10. Prestige (L, US) Pharmaceuticals
10. Prestige (L, US) Pharmaceuticals
45
53
43
74
October 10, 2024. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
D.J. US Pharmaceutical Top 10: Combined Investment Strategy
TOP 10 Combined Investment Strategy
COMBINED
VALUE
GROWTH
360° VIEW
1. Assertio Therapeutics (S, US) Pharmaceuticals
1. Assertio Therapeutics (S, US) Pharmaceuticals
100
73
63
92
2. Phibro Animal (L, US) Pharmaceuticals
2. Phibro Animal (L, US) Pharmaceuticals
100
99
63
85
3. Merck & Co. (XXL, US) Pharmaceuticals
3. Merck & Co. (XXL, US) Pharmaceuticals
83
75
69
85
4. Pacira BioSciences (M, US) Pharmaceuticals
4. Pacira BioSciences (M, US) Pharmaceuticals
78
91
3
45
5. Nektar (S, US) Pharmaceuticals
5. Nektar (S, US) Pharmaceuticals
72
9
79
34
6. Amphastar (M, US) Pharmaceuticals
6. Amphastar (M, US) Pharmaceuticals
61
31
69
74
7. Pfizer (XXL, US) Pharmaceuticals
7. Pfizer (XXL, US) Pharmaceuticals
59
99
39
67
8. Johnson & Johnson (XXL, US) Pharmaceuticals
8. Johnson & Johnson (XXL, US) Pharmaceuticals
49
57
25
40
9. Prestige (L, US) Pharmaceuticals
9. Prestige (L, US) Pharmaceuticals
43
53
43
74
10. Eli Lilly (XXL, US) Pharmaceuticals
10. Eli Lilly (XXL, US) Pharmaceuticals
41
17
97
56
October 10, 2024. Top 10s are published weekly following the Top 10 schedule . (Log in or sign up for more stocks)
☀ This company has a special achievement which is documented on its stock research page.
Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards .
Top 10 Stocks from the purely fact-based Obermatt Method in the stock index Dow Jones U.S. Pharmaceuticals Index from October 10, 2024.
Top 10 Stock History D.J. US Pharmaceutical
Select Top 10 Date
Oct‑2024
Feb‑2024
Jul‑2023
Dec‑2022
Apr‑2022
Aug‑2020
Mar‑2020
Oct‑2019
Apr‑2019
Nov‑2018
Jun‑2018
Oct‑2017
Apr‑2017
Jan‑2017
Jan‑2016
Jan‑2015
Obermatt Portfolio Performance We’re so convinced about our research, that we buy our stock tips. See the performance of the Obermatt portfolio .